Decreased bcl-2 expression in segmental renal dysplasia suggests a role in its morphogenesis

British Journal of Urology

Volumn 80, Issue 1, 1997, Pages 140-144

  Granata, C ^a,b   Wang, Y ^a   Purl, P ^a   Tanaka, K ^a   O'Briain, D S ^a  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

Author keywords

Apoptosis; bcl 2; Duplex kidney; Renal dysplasia

Indexed keywords

PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; FEMALE; HENLE LOOP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; KIDNEY CAPSULE; KIDNEY DISTAL TUBULE; KIDNEY DUPLICATION; KIDNEY DYSPLASIA; MALE; MESENCHYME; MORPHOGENESIS; PRIORITY JOURNAL; PROTO ONCOGENE;

EID: 0031396543     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1997.00235.x     Document Type: Article

References (19)

1. Glassberg KI, Filmer RB. Renal dysplasia, renal hypoplasia and cystic disease of the kidney. In Kelalis PP, King LR, Belman AB eds, Clinical Paediatric Urology, 3rd edn. Vol. II. Philadelphia: Saunders, 1992: 1121-84
2. Atwell JD, Cook PL. Howell CJ. Familial incidence of bifid double ureters. Arch Dis Child 1974: 49: 390-3
3. Hartman GW. Hodson CJ. The duplex kidney and the related abnormality. Clin Radiol 1969; 20: 387
4. LeBrun DP, Warnke RA, Cleary ML. Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am ] Pathol 1993; 142: 743-53
5. Qi-Long Lu, Poulsom R. Wong L, Hanby A. Bcl-2 expression in adult and embryonic non-haematopoietic tissues. / Pathol 1993; 169: 431-7
6. Chandler D, El-Naggar AK. Brisbay S, Redline RW, McDonnell TJ. Apoptosis and expression of the bcl-2 protooncogene in the foetal and adult human kidney. Human Pathol 1994; 25: 789-96
7. Sorenson CM, Rogers SA. Korsmeyer SJ, Hammerman MR. Fulminant metanephric apoptosis and abnormal kidney development in bcl-2 deficient mice. Am ] Physiol 1995; 268:F73-81
8. Kamada S. Shimono A. Yoshitaka S et al. Bcl-2 deficiency in mice leads to pleiotropic abnormalities: accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation and distorted small intestine. Cancer Res 1995; 55: 354-9
9. Yunis JJ. Multiple recurrent genomic defects in follicular lymphoma. N Engl }Med 1984; 316: 79-84
10. Hockenberry D, Nunez G, Milliman C. Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondria! membrane protein that blocks programmed cell death. Nature 1990; 48: 334-6
11. Hockenberry D.. Zutter M, Hickey W. Bcl-2 protein is topographically restricted in tissues characterised by apoptotic cell death. Proc Natl Acad Sci USA 1991; 88: 6961-5
12. Thompson HJ, Strange R, Schedin PJ. Apoptosis in the genesis and prevention of cancer. Cancer Epidem 1992; 1: 597-602
13. Woo D. Apoptosis and loss of renal tissue in polycystic kidney diseases. N Engl ] Med 1995; 333: 18-25
14. Harrison DJ. Cell death in the diseased glomerulus. Histopathology 1988; 12: 679-83
15. Gobe GC, Axelsen RA, Searle JW. Cellular events in experimental unilateral ischémie renal atrophy and in regeneration after controlateral nephrectomy. Lab Invest 1990: 63: 770-9
16. Gobe GC, Axelsen RA. Genesis of renal tubular atrophy in experimental hydronephrosis in the rat. Lab Invest 1987; 56: 273-81
17. Sanders EJ, Wride MA. Programmed cell death in development. Int Rev Cytol 1995; 163: 105-73
18. Umemura S, Kawai K, Osamura RY, Tsutsumi Y. Antigen retrieval for bcl-2 protein in formalin-fixed, paraffinembedded sections. Pathol M 1995; 45: 103-7
19. Igarashi P. Transcription factors and apoptosis in kidney development. Curr Opin Nephrol Hypertension 1994; 3: 308-17